Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, increasing cytotoxic T-cell infiltration and reducing immunosuppressive ...

As highlighted by Towards Packaging research, the global barrier coatings for packaging market, valued at USD 13.4 billion in ...